home > events calendar > more about event

MedTech Integrates 2021

Life Science Integrates

22 June 2021

Inspired by the success of the inaugural MedTech Integrates in last October, Life Science Integrates is delighted to announce the second Medtech Integrates conference. This one-day gathering of technology, diagnostics, devices and therapeutics organisations, as well as clinicians and regulators, provides a platform to discuss the major challenges impacting the MedTech sector.

Broadcast live on 22 June 2021, Medtech Integrates addresses the needs of the MedTech community to overcome the challenges needed to achieve a transformation of diagnostics and devices in healthcare.

This year our three core themes are for the event are:

Detection: Disease detection is key to diagnosis and treatment. How are we accelerating the clinical translation of MedTech, and is it impacting wealth as well as health?

Reflection: 2020 was an unprecedented year. What impact has it had on medtech development and commercialisation?

Projection: What does the future hold for virtual clinical consultations and trials, data sharing and disease prediction? And how will regulations change?

For more information and to view our agenda and high-profile speakers please go to

To register for a complimentary delegate pass, please register here by 17:00 on 20 June 2021 and use promo codeEBR25

phone +44 (0) 20 8667 9551
email 4 Horsley House, 7a Red Lion Lane, London, SE18 4JG, United Kingdom
Print this page
Send to a friend
Industry Events

Pharma Integrates 2021

16 November 2021, VIRTUAL CONFERENCE

Now in its tenth year, Pharma Integrates is a unique event bringing together pharma and healthcare leaders across the Pharmaceutical pipeline to address their needs, to share insights and create debate on crucial topics that influence the future of patient outcomes.
More info >>

White Papers

Bio/Pharmaceutical Methods: Do your Analytical Methods Hold Up to Regulatory Scrutiny?

Eurofins BioPharma Product Testing

As FDA guidelines evolve and drug products on the market begin to age, bio/pharmaceutical manufacturers face scrutiny of the original methods used to support these products. Therefore, manufacturers must re-evaluate these methods to ensure they comply with current FDA expectations. Some manufacturers are even facing consent decrees imposed by the agency requiring them to bring methods up to current standards within a specified timeframe. This exercise requires significant amounts of time and resources, which many manufacturers do not have since they are focused on getting their next products to market. For that reason, some clients have been turning to Eurofins Lancaster Laboratories for support.
More info >>

News and Press Releases

SICK Goes Flat Out for Performance with Mini Smart Sensors

SICK has launched the versatile W4F family of miniature smart sensors, developed to achieve next-generation detection performance and incorporating powerful new optical technologies, each purpose-designed to master common sensing challenges in pharmaceuticals with complete reliability.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement